AI-Powered Sepsis ImmunoScore Tool Receives FDA Approval – Revolutionizing Patient Risk Assessment!
Chicago, Illinois – A Chicago-based startup, Prenosis, has developed a groundbreaking tool called Sepsis ImmunoScore, aimed at revolutionizing the way clinicians assess a patient’s risk of sepsis. By utilizing artificial intelligence, the tool analyzes 22 different parameters, such as temperature, heart rate, and cell counts, to generate an overall risk score and four categories indicative of a patient’s risk of deterioration. The Sepsis ImmunoScore tool, built on Prenosis’ Immunix platform using a dataset of over …